CPT code 90732 denotes administration of the pneumococcal polysaccharide vaccine (PPSV) by intramuscular or subcutaneous injection for individuals aged two years and older. This preventive immunization reduces risk of invasive pneumococcal disease, including meningitis and pneumonia, and is a routine element of adult and certain pediatric vaccination programs. Nationally, pneumococcal vaccination is a key public health measure that influences outpatient immunization workflows, supply management, and preventive care quality metrics.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage considerations, typical sites of service (ambulatory and outpatient settings), and the clinical context surrounding use of the vaccine for eligible patients. The publication summarizes common billing modifiers and service-line implications, and highlights benchmarks and policy updates relevant to immunization billing practice. It also outlines typical documentation elements and places the code within broader preventive care and population health efforts. Data not available in the input is noted where applicable.